Free Trial

Lipocine (LPCN) Institutional Ownership

Lipocine logo
$3.04 +0.02 (+0.66%)
Closing price 08/14/2025 03:59 PM Eastern
Extended Trading
$3.03 -0.01 (-0.46%)
As of 08/14/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)

Current
Institutional Ownership
Percentage
9.11%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$15.85K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$20.98K
Get LPCN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LPCN Institutional Buying and Selling by Quarter

Lipocine Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2025 Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673%
2/12/2025 Geode Capital Management LLC57,464$280K0.0%+6.0%1.074%
8/9/2024 Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480%
8/9/2024 Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222%
1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275%
10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353%
7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563%
6/5/2023EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288%
5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855%
2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084%
2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332%
2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094%
11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106%
8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059%
7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084%
7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164%
5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743%
5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133%
4/26/2022Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347%
2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499%
2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687%
11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357%
11/10/2021Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355%
11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027%
10/19/2021Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282%
8/16/2021State Street Corp304,617$426K0.0%+2,356.6%0.345%
8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196%
8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071%
8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861%
8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321%
8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023%
8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125%
8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792%
8/10/2021Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332%
8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023%
8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160%
5/19/2021Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095%
5/18/2021Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063%
5/17/2021Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795%
(Data available from 1/1/2016 forward)

LPCN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LPCN shares?

During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on Lipocine's institutional investors.

What percentage of Lipocine's stock is owned by institutional investors?

9.11% of Lipocine's stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings.

Which institutional investors have been buying Lipocine's stock?

The following institutional investors have purchased Lipocine's stock in the last 24 months: Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K).

How much institutional buying is happening at Lipocine?

Institutional investors have bought a total of 3,248 shares in the last 24 months. This purchase volume represents approximately $15.85K in transactions.

Which of Lipocine's major shareholders have been selling company stock?

The following institutional investors have sold Lipocine stock in the last 24 months: Renaissance Technologies LLC ($4.30K).

How much institutional selling is happening at Lipocine?

Institutional investors have sold a total of 4,300 shares in the last 24 months. This volume of shares sold represents approximately $20.98K in transactions.



This page (NASDAQ:LPCN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners